Skip to content

An Safety Study to evaluate the effectiveness of Kalimera hair oil on Human hair health for hair Growth, Hair Strength, Hair Lustrous and Dandruff prevention

An Open label, Clinical Safety Study to evaluate the effectiveness of Kalimera hair oil on Human hair health for Hair Growth, Hair Strength, Hair Lustrous and Dandruff prevention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019022
Enrollment
50
Registered
2019-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Kalimera hair oil: Take required quantity of hair oil and gently massage over scalp, twice a day for 3months (90 days) Control Intervention1: NA: NA

Sponsors

BioVein Innovations Solutions Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male and female volunteers 18-50 years old, inclusive. Able to provide informed consent after risks and benefits of the study have been explained. Be willing to undergo all study procedures Ability to communicate effectively with study personnel. Agree to abstain from use of any hair growth affecting oral or topical medication including over the counter and herbal medications, minoxidil, finasteride or dutasteride during the course of this study; also agrees to abstain from shaving the head during the course of the study

Exclusion criteria

Exclusion criteria: Women who are pregnant or lactating. Subjects who took any medicine which can affect the hair growth in recent 3 months. Subjects who have used minoxidil or any oral or topical medication including over the counter and herbal medications for the treatment of hair loss within 6 months of study screening, or finasteride or dutasteride within 12 months of study screening. Subjects with scalp / skin infection, history of hypersensitivity to study products which may interfere in the study. Received any other investigational medicinal therapy within 30 days and topical therapy within 7 days prior to screening Patient suffering from any active general illness or have history of any general illness.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of kalimera hair oil in the improvement of Hair growth (Trichoscan technique), Hair strength (Universal Tensile Testing Machine (UTM) and Improvement in scalp dandruff (By adherent scalp flaking score).Timepoint: day0 day90

Secondary

MeasureTime frame
Compare the changes in Manual assessment of hair loss by One min (60sec) comb test or hair count test from screening visits to end of visits. Self-assessment of hair lustrous(shininess) by subjective questionnaires atTimepoint: Day 0 and Day 90

Countries

India

Contacts

Public ContactDivya C

BioAgile Therapeutics Pvt Ltd

pm@bioagiletherapeutics.com08043754520

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026